实验室单品

首页 / 实验室单品 / 实验室单品

CAS:1420043-61-3|Tolfenamic acid-13C6

  • 产品货号:DT2025061735
  • 发布时间:2025-06-06
  • 产品CAS :1420043-61-3
  • 产品规格:mg(更多包装需求请咨询客服)
  • 产品纯度:≥98%
  • 产品货期:现货下单后48小时内发货,定制产品4-8周。
  • 运输条件:顺丰常规运输
询价
产品详情

货号:DT2025061735
CAS:1420043-61-3
规格:mg(更多包装需求请咨询客服)
纯度:≥98%
生产商:试剂家

生物活性:Tolfenamic acid-13C6 is the 13C6 labeled Tolfenamic acid. Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory and anti-cancer agent, selectively inhibits COX-2, with an IC50 of 13.49 μM (3.53 μg/mL) in LPS-treated (COX-2) canine DH82 monocyte/macrophage cells, but shows no effect on COX-1.
体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
试剂家 has not independently confirmed the accuracy of these methods. They are for reference only.
Tolfenamic acid-13C6 相关抗体:
COX2 Antibody
COX IV Antibody
COX2/Cyclooxygenase 2 Antibody
COX IV Antibody (YA867)
Cyclooxygenase 1 Antibody (YA2537)
Cyclooxygenase 2 Antibody (YA2541)
分子量:267.66
Formula:C813C6H12ClNO2
CAS 号:1420043-61-3
非标记 CAS:13710-19-5
性状:固体
颜色:White to off-white
中文名称:托芬那酸-13C6;托灭酸-13C6
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years
In solvent:-80°C:6 months,-20°C:1 month
纯度 & 产品资料
纯度: 99.7%
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
 [Content Brief]
[2]. Kay-Mugford P, et al. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res. 2000 Jul;61(7):802-10.
 [Content Brief]
[3]. Maliakal P, et al. Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats. Invest New Drugs. 2012 Jun;30(3):853-61.
 [Content Brief]
[4]. Sankpal UT, et al. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. Oncotarget. 2017 Feb 28;8(9):14593-14603
 [Content Brief]

常见基团 common groups
Online message

在线留言

欢迎您访问“试剂家 | 纳米靶向科研平台”官方网站,请留下您的需求,我们会派专业人员及时与您联系,并为您提供相应的产品方案。

* 咨询产品
* 您的姓名
* 联系电话
留言内容
验证码
Related Products

相关产品